Cinclus Pharma Holding AB (publ) – Trademark Portfolio
Entity Type: 98
Cinclus Pharma Holding AB (publ) holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 2 filings in this category. The portfolio also extends into Class 44 (Medical Services) across 3 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include CINCLUS.
Kungsbron 1
Floor 3 Elevator G SE-111 22 Stockholm
Showing of trademarks Trademarks
Trademark Classifications
Cinclus Pharma Holding AB (publ)'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific and technological services; industrial analysis and research services
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does Cinclus Pharma Holding AB (publ) have?
Cinclus Pharma Holding AB (publ) has 2 U.S. trademarks filed with the USPTO. Of these, 2 registered.
What trademark classes does Cinclus Pharma Holding AB (publ) file in?
Cinclus Pharma Holding AB (publ) files trademarks across 3 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 5 (Pharmaceuticals). Class 42 covers scientific and technological services; industrial analysis and research services.
What are Cinclus Pharma Holding AB (publ)'s most well-known trademarks?
Cinclus Pharma Holding AB (publ)'s registered trademark portfolio includes well-known marks such as CINCLUS. These are among 2 currently registered trademarks in the portfolio.
What is Cinclus Pharma Holding AB (publ)'s trademark registration success rate?
Cinclus Pharma Holding AB (publ) has a 100% trademark registration rate, with 2 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.